US states file second amended complaint in generic drug pricing antitrust litigation
MLex Summary: US state plaintiffs filed their second amended antitrust complaint against Sun Pharmaceutical, Lannett, Mylan Pharmaceuticals and other generic drug makers over pricing.See attached file. ...To view the full article, register now.
Already a subscriber? Click here to view full article